Walks a cardiologist through whether, where and how to order a germline genetic test for a suspected inherited cardiovascular disease: indication, written consent (with assent for minors), pre-test counseling, choice of test and laboratory, handling of VUS and secondary findings, and privacy. Use when a clinician asks 'should I order a genetic test', 'how do I consent for a cardiomyopathy or long QT gene panel', 'can I test this child or relative (cascade screening)', 'what do I tell the patient about VUS or a negative result', or 'where can this test be sent'. Based on the JCS/JCC/JSPCCS 2024 guideline; Japan-specific insurance and legal details are flagged.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Determines if patient meets ICD-10 criteria for transsexualism. Triggered when a clinician uses ICD-10 for diagnostic purposes in gender identity assessment.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Determines whether an adult patient meets eligibility criteria for initiating gender-affirming hormone therapy. Triggered when an adult patient requests gender-affirming hormones or presents for evaluation of hormone therapy eligibility.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
This skill confirms whether a hospital has the necessary policies and expertise to support inpatient insulin pump therapy, including informed consent, standardized order sets, and device management guidance for imaging and surgical procedures. Triggered by questions such as "Are hospital policies and expertise in place for insulin pump use?" to ensure safe continuation of pump therapy in noncritical illness.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
This skill suggests using real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D). Trigger phrases include "Should I use RT-CGM+ADIP or MDI+SMBG for this T1D patient?" or "Is intensive pump therapy indicated for this patient?"
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Evaluates cardiovascular risk factors in persons receiving hormone therapy by obtaining fasting lipid profiles and diabetes screening. Triggered when a patient is on gender-affirming hormone therapy and due for routine cardiovascular risk assessment.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
This skill checks for contraindications or sources of inaccuracy that may affect continuous glucose monitoring (CGM) reliability in hospitalized adults. It is triggered when clinicians ask, “Are there factors that could make CGM unreliable?” or when assessing for skin infection, hypoperfusion, hypovolemia, vasoactive/pressor therapy, or medications such as acetaminophen >4 g/day, dopamine, vitamin C, or hydroxyurea.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
This skill suggests continuing personal CGM with or without ADIP rather than discontinuation for inpatients already using it who are at high risk for hypoglycemia. Trigger phrases include "Should I continue or discontinue personal CGM for this inpatient who is already using it?" and "Is it appropriate to maintain personal CGM during hospitalization?"
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Considers adapting the basal insulin rate at hospital admission for patients using insulin pump therapy. Triggered by clinician questions such as "Should we adjust the basal rate upon admission for pump therapy?" or when evaluating pump continuation versus transition to scheduled subcutaneous insulin.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Assess whether a hospitalized adult with diabetes on insulin pump therapy remains a candidate for continued inpatient pump use. Consider triggers such as the clinician asking "Is this patient appropriate to continue insulin pump in hospital?" and evaluate for impaired consciousness, inability to adjust pump settings, critical illness, DKA, or hyperosmolar hyperglycemic state.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
If CGM fails or is removed, revert the insulin pump to manual mode provided basic criteria for pump use in hospital are still met. Trigger phrase: "CGM failed, should we switch pump to manual mode?
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Transition insulin pump to scheduled subcutaneous basal bolus insulin when anticipated hospital length of stay exceeds 1 to 2 days and pump expertise is unavailable. Triggers include: "Patient expected to stay >2 days, should we switch pump to scheduled insulin?
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
This skill guides individualized prostate cancer screening for transgender females receiving estrogen therapy based on personal risk. Trigger phrase: transgender female receiving estrogens.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
This skill determines whether an adolescent or adult patient meets DSM-5 criteria for gender dysphoria (gender incongruence) by evaluating the presence of at least two of six specified criteria over a minimum 6-month duration, accompanied by clinically significant distress or impairment. It is triggered when a clinician queries whether the patient's reported symptoms align with gender dysphoria, such as persistent incongruence between experienced/expressed gender and designated gender.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Suggests initiating inpatient CGM for select diabetic patients at high risk for hypoglycemia based on Table 3 criteria. Triggers include "Should I initiate CGM for this hospitalized diabetic patient at high risk for hypoglycemia?" or "Is inpatient CGM warranted for this patient?"
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Suggests short-term, intermittent real-time CGM use in adult patients with type 2 diabetes not on prandial insulin who have A1C ≥7% and are willing and able to use the device. Triggered by phrases such as “T2DM basal-only, A1C ≥7%, consider intermittent CGM” or “Short-term CGM for non-prandial T2DM with elevated A1C”.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
If CGM is not available, continue monitoring blood glucose with point-of-care testing as an alternative option. Trigger phrases include: "CGM is not available, what should we use for glucose monitoring?
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
This skill suggests using real-time continuous glucose monitoring (CGM) rather than no CGM for outpatients with type 2 diabetes (T2D) who take insulin and/or sulfonylureas and are at high risk for hypoglycemia. It is triggered by clinician questions such as "Should I use CGM for this T2D patient on insulin or sulfonylureas with high hypoglycemia risk?" or "Is CGM indicated for this patient?"
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Apply the four published expert-consensus clinical scenarios to manage GI adverse events in complex GLP-1 receptor agonist patients — persistent nausea mid-titration, GERD/heartburn after up-titration, elderly with sarcopenia risk, and insulin-treated elderly with CKD plus diarrhoea. Use when a clinician describes a patient resembling one of these archetypes, or asks "how to manage GLP-1 in an elderly patient with CKD", "patient on liraglutide developed reflux", "sarcopenia worry on semaglutide in 80-year-old", or "persistent nausea on semaglutide despite escalation". Grounded in Gorgojo-Martínez 2023 Table 4.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 5일 업데이트
This skill determines whether inpatient diabetic patients meet high-risk criteria for CGM initiation using Table 3 factors such as age ≥65 years, BMI ≤27 kg/m², type 1 diabetes, insulin regimen, and specific clinical conditions. It is triggered by clinician questions like "Should I assess this inpatient for CGM initiation based on hypoglycemia risk?" or "Is this patient a candidate for inpatient CGM?"
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
This skill determines whether a patient using a hybrid closed-loop insulin pump can continue this therapy upon hospital admission. It is triggered by questions such as "Can hybrid closed-loop pump be continued given hospital constraints?"
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Recommends RT-CGM devices for adult patients with well-controlled type 1 diabetes who are willing and able to use the devices on a nearly daily basis. Trigger phrases include 'Controlled T1DM patient interested in CGM' and 'Consider RT-CGM for glycemic stability in well-controlled T1DM'.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Provides schedule for monitoring during sex hormone induction. Trigger: patient initiating gender-affirming hormone therapy (GAHT).
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트
Assists clinicians in determining whether to proceed with social transition for prepubertal youth experiencing gender dysphoria or gender incongruence. Triggers include prepubertal youth with GD/gender incongruence and discussions about initiating social transition.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
dromlakhani/MD2SKILL☆ 142026년 10월 20일 업데이트